The Intriguing Links between Psoriasis and Bullous Pemphigoid

Article Dermatology

Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report

Jenny S. W. Yun et al.

Summary: This case report demonstrates the first case of secukinumab achieving a dramatic clinical improvement of both chronic psoriasis and active BP.

AUSTRALASIAN JOURNAL OF DERMATOLOGY (2022)

添加到收藏夹

Review Dermatology

Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature

Martina Burlando et al.

Summary: Drug-induced bullous pemphigoid (DBP) associated with biologics for psoriasis is rare and may spontaneously regress after discontinuation of the triggering drug, responding rapidly to steroid therapy. Despite being a rare side effect, it is important to document and address the increasing side effects of biologic therapies as new molecules are constantly being developed and administered to psoriatic patients.

DERMATOLOGIC THERAPY (2022)

添加到收藏夹

Review Dermatology

Biologic treatment outcomes in mucous membrane pemphigoid: A systematic review

Yuliya Lytvyn et al.

Summary: This systematic review found that biologic agents, including intravenous immunoglobulin, rituximab, and tumor necrosis factor α inhibitors, showed promising efficacy in patients with MMP. However, further randomized clinical trials with long-term follow-up are necessary to confirm their safety and effectiveness.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

添加到收藏夹

Letter Dermatology

Incidental amelioration of bullous pemphigoid during ixekizumab treatment for psoriasis

Lingyi Lu et al.

JOURNAL OF DERMATOLOGY (2022)

添加到收藏夹

Review Medicine, Research & Experimental

Bullous pemphigoid: An immune disorder related to aging

Maria Ludovica Deotto et al.

Summary: Bullous pemphigoid (BP) is the most common subepidermal autoimmune blistering disease caused by autoantibodies attacking two principal antigens. The pathogenesis of BP involves genetic predisposition, skin changes due to aging, and specific triggers. Recognition of triggering factors and comorbidities is important for understanding and managing BP. Treatment strategies should focus on restoring skin barrier integrity and maintaining skin homeostasis, particularly in the elderly.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes

Ya-Chu Tsai et al.

Summary: Psoriasis and atopic dermatitis are now considered to be a spectrum of disease, with overlapping genetic loci and immunopathogenesis. The clinical presentations also have similarities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Rheumatology

Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review

Nanette L. A. Vincken et al.

Summary: While systemic glucocorticoids (SGC) are traditionally discouraged in the treatment of psoriatic arthritis (PsA) and psoriasis, they are frequently prescribed for these patients. However, studies show that the occurrence of psoriatic flares appears to be low upon SGC exposure. In patients with a clear indication for SGC, consideration should be given to the low risk of skin flaring, while also weighing the risks of short- and long-term SGC-related side effects.

RHEUMATOLOGY (2022)

添加到收藏夹

Article Dermatology

Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation

Dennis Niebel et al.

Summary: This study aimed to analyze the clinical and histopathological differences between patients with bullous pemphigoid (BP) who also have psoriasis or receive immune-checkpoint blockade (ICB) therapy and patients with idiopathic BP. The study found that ICB-associated BP affects men more often and might show mucosal involvement more frequently. However, there were no statistically significant dermatopathological differences among the different groups.

DERMATOPATHOLOGY (2022)

添加到收藏夹

Article

Psoriasis, sarcoidosis, and bullous pemphigoid: more than a coincidence in a single patient?

Juan Escalas et al.

Dermatology Online Journal (2022)

添加到收藏夹

Review Dermatology

Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review

Chang-Yu Hsieh et al.

Summary: Psoriasis and bullous pemphigoid often coexist and have different optimal treatment strategies. Topical corticosteroids are commonly used for mild cases, while systemic immunosuppressants such as corticosteroids and methotrexate are popular choices for more severe cases. However, tapering of immunosuppressants may lead to flare-ups of both diseases.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)

添加到收藏夹

Article Dermatology

Concurrent bullous pemphigoid and plaque psoriasis successfully treated with Janus kinase inhibitor Baricitinib

Yue Xiao et al.

Summary: This case report describes a successful treatment of a Chinese man with concurrent plaque psoriasis and bullous pemphigoid using the Janus kinase inhibitor Baricitinib. Significant improvement in skin lesions and pruritus was observed, and complete remission was achieved without any adverse effects at the 24-week follow-up.

DERMATOLOGIC THERAPY (2022)

添加到收藏夹

Review Dermatology

Bullous pemphigoid induced by biologic drugs in psoriasis: a systematic review

Husein Husein-ElAhmed et al.

Summary: This study accurately estimates the burden of BIBP, with ustekinumab presenting the most evidence of BIBP. Different cytokine pathways and clinical course patterns exist between BPs induced by TNF-alpha blockers and ustekinumab. Prior to commencing any biologic therapy, a careful screening of previous history of bullous diseases and baseline immunologic study in psoriatic patients is advisable.

JOURNAL OF DERMATOLOGICAL TREATMENT (2022)

添加到收藏夹

Letter Dermatology

Bullous pemphigoid during the treatment of psoriasis vulgaris with risankizumab

Norihito Fukada et al.

JOURNAL OF DERMATOLOGY (2022)

添加到收藏夹

Article Dermatology

Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)

L. Borradori et al.

Summary: The background provides detailed information about bullous pemphigoid (BP) and its impact on patients. The objective of the study is to update the guidelines for managing this disease. The results suggest that treatment should be tailored based on the severity of BP and patients' comorbidities. High-potency topical corticosteroids are recommended as the main treatment, while the use of doxycycline and dapsone is controversial. B-cell-depleting therapy and intravenous immunoglobulins can be considered in treatment-resistant cases. The final version of the guideline received consent from several patient organizations.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

添加到收藏夹

Review Immunology

Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review

Peng Cao et al.

Summary: Rituximab, omalizumab, and dupilumab have similar clinical benefits for patients with bullous pemphigoid, but rituximab leads to higher recurrence rates, adverse events, and mortality rates.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases

Fumi Miyagawa

Summary: Targeted biologic agents have had a significant impact on the treatment of immune-mediated inflammatory diseases. While they can greatly improve clinical symptoms, they also come with adverse reactions, including paradoxical reactions. Their efficacy in targeting specific cytokines and the presence of paradoxical reactions have helped researchers understand the underlying molecular pathways of these diseases.

BIOMEDICINES (2022)

添加到收藏夹

Letter Dermatology

Ixekizumab successfully treated refractory psoriasis concurrent bullous pemphigoid

Yue Xiao et al.

JOURNAL OF DERMATOLOGY (2022)

添加到收藏夹

Article Dermatology

Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report

Wenjuan Chen et al.

Summary: This case report presents a rare occurrence of bullous pemphigoid (BP) in a woman with severe erythrodermic psoriasis (EP), possibly triggered by beta hemolytic streptococcus infection. This highlights the need for physicians to be attentive to the complicated condition of such patients and further study for better treatment.

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2022)

添加到收藏夹

Letter Dermatology

Refractory bullous pemphigoid with prurigo nodularis successfully treated with dupilumab monotherapy

Po-Ta Lai et al.

DERMATOLOGICA SINICA (2022)

添加到收藏夹

Editorial Material Pharmacology & Pharmacy

Bullous pemphigoid induced by ustekinumab: a case report

Marta Marin et al.

Summary: A case of possible bullous pemphigoid (BP) associated with ustekinumab treatment was reported in a 75-year-old woman. The patient presented with new lesions shortly after receiving the fifth dose, which resolved with corticosteroid and dapsone treatment. Three causality algorithms suggested a probable causal relationship, highlighting the importance of considering drug side effects in prescribing therapies.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2021)

添加到收藏夹

Review Dermatology

Role of regulatory T cells in psoriasis pathogenesis and treatment

L. Nussbaum et al.

Summary: Psoriasis is a chronic inflammatory disease with a strong genetic component that can be triggered by environmental factors. Tregs play a fundamental role in immune homeostasis and contribute to the prevention of autoimmune disease by suppressing immune responses, but their functional regulation remains unclear in the context of psoriasis.

BRITISH JOURNAL OF DERMATOLOGY (2021)

添加到收藏夹

Article Dermatology

Patients with bullous pemphigoid and comorbid psoriasis present with less blisters and lower serum levels of anti-BP180 autoantibodies

S. Staender et al.

Summary: Patients with both BP and psoriasis present at a younger age with a milder disease phenotype, lower levels of pathogenic autoantibodies, and specific linear C3 deposits along the dermal-epidermal junction detected by direct immunofluorescence microscopy.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

添加到收藏夹

Article Dermatology

Could basement membrane alterations, resembling micro-wounds at the dermo-epidermal junction in psoriatic non-lesional skin, make the skin susceptible to lesion formation?

Renata Bozo et al.

Summary: The tissue microenvironment plays a crucial role in regulating immune functions. Studying the constitutively abnormal functions of clinically uninvolved psoriatic skin can provide insights into psoriasis pathobiology. Abnormalities at the dermal-epidermal junction region in non-lesional skin may contribute to the development of the disease.

EXPERIMENTAL DERMATOLOGY (2021)

添加到收藏夹

Article Dermatology

Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis

Anna R. F. Gregoire et al.

Summary: This study found that the rate of psoriasis flares in adult patients with a known history of psoriasis during or within 3 months after concluding systemic corticosteroid administration was very low, especially for severe flares. The results suggest that systemic steroids may be much less likely to trigger severe flares in patients with psoriasis.

JAMA DERMATOLOGY (2021)

添加到收藏夹

Letter Dermatology

Case of bullous pemphigoid under treatment with adalimumab for hidradenitis suppurativa

Makoto Sugaya et al.

JOURNAL OF DERMATOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Psoriasis

Christopher E M Griffiths et al.

LANCET (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Pustular Psoriasis: From Pathophysiology to Treatment

Giovanni Genovese et al.

Summary: Pustular psoriasis is a clinicopathological entity with different variants characterized by sterile pustules on an erythematous base, showing intense inflammatory response and involvement of the IL-36 axis. Due to the rarity and heterogeneity of PP forms, data on prognosis and therapeutic management are limited, leading to ongoing debates on the diagnosis and treatment of PP.

BIOMEDICINES (2021)

添加到收藏夹

Review Medicine, General & Internal

A blistering new era for bullous pemphigoid: A scoping review of current therapies, ongoing clinical trials, and future directions

Subaina Naeem Khalid et al.

Summary: Bullous pemphigoid (BP) is a severe autoimmune blistering skin disorder that primarily affects the older population, with increasing prevalence. Current treatment modalities include corticosteroids, non-immunosuppressive agents, and immunosuppressants, but they are often associated with toxicities and high recurrence rates. Efforts are being made to develop newer targeted therapies to provide safer alternatives.

ANNALS OF MEDICINE AND SURGERY (2021)

添加到收藏夹

Review Dermatology

Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy

Anastasios Karamanakos et al.

Summary: The study reviewed published cases of induced or exacerbated psoriasis after biologic therapy other than anti-TNF-alpha agents, finding cases of paradoxical psoriasis after ustekinumab and secukinumab treatment, which are approved therapies for psoriasis. Awareness among physicians regarding early recognition of paradoxical psoriasis is crucial.

EUROPEAN JOURNAL OF DERMATOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

The Defect in Regulatory T Cells in Psoriasis and Therapeutic Approaches

Naoko Kanda et al.

Summary: Psoriasis is characterized by an imbalance in CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) and alterations in gut microbiota. Therapeutic agents targeting Tregs, such as anti-IL-23 or anti-IL-17A antibodies, retinoids, and probiotics/prebiotics, show promise in restoring Treg function and alleviating psoriasis symptoms.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Review Medicine, General & Internal

Molecular Pathogenesis of Psoriasis and Biomarkers Reflecting Disease Activity

Masaru Honma et al.

Summary: Psoriasis is a chronic inflammatory skin disease with bothersome symptoms, but recent advances in molecular-targeted therapies have shown promising clinical effects in treating severe symptoms and related skin diseases. Biomarkers such as cytokines, chemokines play a crucial role in defining therapeutic strategies, and blood protein markers show great potential in daily clinical practice.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications

Rohan Singh et al.

Summary: Psoriasis is a chronic, systemic inflammatory disease caused by uncontrolled keratinocyte proliferation and immune system dysregulation. Biological therapies targeting cytokine-mediated pathogenesis have shown improvement in patient quality of life. Approved biological therapies target cytokines TNF-alpha, IL-17, and IL-23 for the treatment of moderate to severe psoriasis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Allergy

Significance of interleukin-31 (IL-31) gene polymorphisms and IL-31 serum level in psoriasis in correlation with pruritus

Dorota Purzycka-Bohdan et al.

Summary: This study examined the impact of IL-31 gene polymorphisms and serum IL-31 levels on psoriasis and pruritus, finding distinct IL-31 promoter gene polymorphisms may be involved in psoriasis development. However, serum IL-31 levels did not correlate with disease severity, onset, psoriatic arthritis or pruritus intensity, suggesting IL-31 may not be a reliable marker for psoriatic pruritus.

POSTEPY DERMATOLOGII I ALERGOLOGII (2021)

添加到收藏夹

Review Dermatology

Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review

Frederick T. Gibson et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)

添加到收藏夹

Review Medicine, General & Internal

Factors associated with the activity and severity of bullous pemphigoid: a review

Yangchun Liu et al.

ANNALS OF MEDICINE (2020)

添加到收藏夹

Article Dermatology

Distinct compartmentalization of immune cells and mediators characterizes bullous pemphigoid disease

Camilla Margaroli et al.

EXPERIMENTAL DERMATOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Bullous Pemphigoid: Trigger and Predisposing Factors

Francesco Moro et al.

BIOMOLECULES (2020)

添加到收藏夹

Article Medicine, General & Internal

The Bidirectional Association Between Bullous Pemphigoid and Psoriasis: A Population-Based Cohort Study

Khalaf Kridin et al.

FRONTIERS IN MEDICINE (2020)

添加到收藏夹

Review Dermatology

A Systematic Review of Drug-associated Bullous Pemphigoid

Matthew J. Verheyden et al.

ACTA DERMATO-VENEREOLOGICA (2020)

添加到收藏夹

Article Immunology

The role of T cells in pemphigus vulgaris and bullous pemphigoid

Hui Fang et al.

AUTOIMMUNITY REVIEWS (2020)

添加到收藏夹

Article Allergy

Doxycycline as an initial treatment of bullous pemphigoid in Japanese patients

Kiyoto Kimura et al.

JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY (2020)

添加到收藏夹

Article Dermatology

Simultaneous bullous pemphigoid and vitiligo associated with adalimumab therapy in a patient with psoriasis vulgaris

Andres Tirado-Sanchez et al.

INDIAN DERMATOLOGY ONLINE JOURNAL (2020)

添加到收藏夹

Review Dermatology

Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies

Kevin Phan et al.

AUSTRALASIAN JOURNAL OF DERMATOLOGY (2019)

添加到收藏夹

Article Immunology

IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid

Lenche Chakievska et al.

JOURNAL OF AUTOIMMUNITY (2019)

添加到收藏夹

Review Immunology

Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid

Eric H. Kowalski et al.

AUTOIMMUNITY REVIEWS (2019)

添加到收藏夹

Article Dermatology

Bullous pemphigoid associated with psoriasis: a good response to methotrexate

Pablo Vargas et al.

ANAIS BRASILEIROS DE DERMATOLOGIA (2019)

添加到收藏夹

Article Dermatology

Psoriasis is associated with increased risk of bullous pemphigoid: A nationwide population-based cohort study in Taiwan

Yi-Hsin Ho et al.

JOURNAL OF DERMATOLOGY (2019)

添加到收藏夹

Article Immunology

NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay

Delphine Giusti et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Review Immunology

Role of the Pruritic Cytokine IL-31 in Autoimmune Skin Diseases

Bernhard F. Gibbs et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Review Immunology

New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update

Giovanni Genovese et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Immunology

Evidence for a role of autoinflammation in early-phase psoriasis

D. Fanoni et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)

添加到收藏夹

Article Immunology

IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid

Sebastien Le Jan et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Review Immunology

Anti-p200 Pemphigoid: A Systematic Review

Khalaf Kridin et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Letter Dermatology

Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid

Masahiro Kamata et al.

JOURNAL OF DERMATOLOGY (2019)

添加到收藏夹

Article Dermatology

Epitope spreading phenomenon: A case report

Keerthana Krishnaswamy et al.

INDIAN DERMATOLOGY ONLINE JOURNAL (2019)

添加到收藏夹

Review Allergy

Psoriasis: from Pathogenesis to Targeted Therapies

Curdin Conrad et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)

添加到收藏夹

Review Immunology

Autoimmunity and autoimmune co-morbidities in psoriasis

Kazuhisa Furue et al.

IMMUNOLOGY (2018)

添加到收藏夹

Review Medicine, General & Internal

Interaction of Psoriasis and Bullous Diseases

Teruki Dainichi et al.

FRONTIERS IN MEDICINE (2018)

添加到收藏夹

Review Medicine, General & Internal

The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations

Khalaf Kridin et al.

FRONTIERS IN MEDICINE (2018)

添加到收藏夹

Letter Dermatology

A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis

J. Loget et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

添加到收藏夹

Letter Dermatology

Development of bullous pemphigoid during secukinumab treatment for psoriasis

Po-Han Ho et al.

JOURNAL OF DERMATOLOGY (2017)

添加到收藏夹

Letter Dermatology

Association between bullous pemphigoid and psoriasis: A case-control study

Khalaf Kridin et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

添加到收藏夹

Article Dermatology

IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants

P. C. Freire et al.

BRITISH JOURNAL OF DERMATOLOGY (2017)

添加到收藏夹

Letter Dermatology

Bullous pemphigoid during ustekinumab therapy in a psoriatic patient

Nahide Onsun et al.

EUROPEAN JOURNAL OF DERMATOLOGY (2017)

添加到收藏夹

Article Dermatology

Role of physical factors in the pathogenesis of bullous pemphigoid: Case report series and a comprehensive review of the published work

Sorina Danescu et al.

JOURNAL OF DERMATOLOGY (2016)

添加到收藏夹

Article Dermatology

Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia

Nobuki Maki et al.

JOURNAL OF DERMATOLOGY (2016)

添加到收藏夹

Letter Dermatology

IL-17 Responses Are the Dominant Inflammatory Signal Linking Inverse, Erythrodermic, and Chronic Plaque Psoriasis

Xianying Xing et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)

添加到收藏夹

Review Dermatology

Erythrodermic psoriasis: pathophysiology and current treatment perspectives

Rasnik K. Singh et al.

PSORIASIS-TARGETS AND THERAPY (2016)

添加到收藏夹

Review Dermatology

Pemphigoid Diseases as a Sign of Active Psoriasis: A Case Report and Brief Review

Mehdi Iskandarli et al.

DERMATOLOGY (2015)

添加到收藏夹

Article Dermatology

Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases

Chika Ohata et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome

Julie Plee et al.

SCIENTIFIC REPORTS (2015)

添加到收藏夹

Editorial Material Dermatology

Remission of Bullous Pemphigoid after Rituximab Treatment in a Psoriasis Patient on Regular Low-dose Methotrexate

Ting-Shun Wang et al.

ACTA DERMATO-VENEREOLOGICA (2014)

添加到收藏夹

Article Pathology

Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound glycyrrhizin

Xiaoqing Si et al.

DIAGNOSTIC PATHOLOGY (2014)

添加到收藏夹

Letter Dermatology

Coexistence of psoriasis vulgaris and vitiligo with bullous pemphigoid: a case report

Marek Jankowski et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)

添加到收藏夹

Article Dermatology

Innate Immune Cell-Produced IL-17 Sustains Inflammation in Bullous Pemphigoid

Sebastien Le Jan et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

添加到收藏夹

Review Dermatology

Drug-induced pemphigoid: a review of the literature

P. G. Stavropoulos et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)

添加到收藏夹

Letter Dermatology

A successful treatment with ustekinumab in a case of antilaminin-γ1 pemphigoid associated with psoriasis

Y. Majima et al.

BRITISH JOURNAL OF DERMATOLOGY (2013)

添加到收藏夹

Article Ophthalmology

Coexistence of psoriasis and bullous pemphigoid: remission with low-dose methotrexate

Umran Gunay et al.

CUTANEOUS AND OCULAR TOXICOLOGY (2013)

添加到收藏夹

Editorial Material Immunology

Psoriasis and susceptibility to other autoimmune diseases: an outline for the clinician

Faisal R. Ali et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)

添加到收藏夹

Letter Dermatology

Case of coexisting psoriatic arthritis and bullous pemphigoid improved by etanercept

Megumi Nin et al.

JOURNAL OF DERMATOLOGY (2013)

添加到收藏夹

Article Dermatology

Missing the target: Characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay

Janet A. Fairley et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)

添加到收藏夹

Article Dermatology

Bullous pemphigoid: From the clinic to the bench

Giovanni Di Zenzo et al.

CLINICS IN DERMATOLOGY (2012)

添加到收藏夹

Article Dermatology

Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response

P. Quaglino et al.

DERMATOLOGY (2011)

添加到收藏夹

Article Dermatology

Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan

Tsen-Fang Tsai et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2011)

添加到收藏夹

Review Dermatology

The role of drugs in the induction and/or exacerbation of psoriasis

Kabbur Hanumanthappa Basavaraj et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2010)

添加到收藏夹

Letter Dermatology

Efalizumab-induced bullous pemphigoid

Tu Anh Duong et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)

添加到收藏夹

Letter Dermatology

Coexisting bullous pemphigoid and psoriasis successfully treated with etanercept

Francesco Cusano et al.

EUROPEAN JOURNAL OF DERMATOLOGY (2010)

添加到收藏夹

Letter Dermatology

Bullous Pemphigoid Occurring during Efalizumab Treatment for Psoriasis: A Paradoxical Auto-Immune Reaction?

Karine Monnier-Murina et al.

DERMATOLOGY (2009)

添加到收藏夹

Article Dermatology

A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy

R. Saraceno et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2008)

添加到收藏夹

Letter Dermatology

Pemphigoid nodularis associated with psoriatic erythroderma: successful treatment with suplatast tosilate

Y. Teraki et al.

BRITISH JOURNAL OF DERMATOLOGY (2008)

添加到收藏夹

Article Dermatology

The clinical spectrum of psoriasis

Luigi Naldi et al.

CLINICS IN DERMATOLOGY (2007)

添加到收藏夹

Article Dermatology

Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship?

Agnes Wilczek et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)

添加到收藏夹

Letter Dermatology

Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept

PS Yamauchi et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)

添加到收藏夹

Article Allergy

Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid

Y Niimi et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2006)

添加到收藏夹

Letter Dermatology

Coexistence of psoriasis vulgaris, bullous pemphigoid and vitiligo: a case report

A Pasic et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2002)

添加到收藏夹

The Intriguing Links between Psoriasis and Bullous Pemphigoid

相关参考文献

导出引文

分享论文